Institute of Pulmonary Medicine
Zvi G. Fridlender has not added Biography.
If you are Zvi G. Fridlender and would like to personalize this page please email our Author Liaison for assistance.
Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion.
Journal of immunology (Baltimore, Md. : 1950) Jun, 2002 | Pubmed ID: 12055266
Pleural effusion.
The New England journal of medicine Oct, 2002 | Pubmed ID: 12393834
Metastatic carcinoma presenting with concomitant eosinophilia and thromboembolism.
The American journal of the medical sciences Aug, 2003 | Pubmed ID: 12920442
Myocardial infarction in a patient with beta-thalassemia major: first report.
American journal of hematology Jan, 2004 | Pubmed ID: 14695633
Recurrent infusion phlebitis induced by cyclosporine.
The Annals of pharmacotherapy Dec, 2004 | Pubmed ID: 15507500
Obstructing tracheal pulmonary Langerhans cell histiocytosis.
Chest Aug, 2005 | Pubmed ID: 16100210
Late-onset sarcoidosis after liver transplantation for primary biliary cirrhosis.
Journal of clinical gastroenterology Mar, 2007 | Pubmed ID: 17426476
Association between cytomegalovirus infection and venous thromboembolism.
The American journal of the medical sciences Aug, 2007 | Pubmed ID: 17700200
B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models.
Journal of immunotherapy (Hagerstown, Md. : 1997) Jun, 2008 | Pubmed ID: 18463540
Bronchoscopy in octogenarians.
Age and ageing Nov, 2008 | Pubmed ID: 18550894
Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.
Cancer research Dec, 2008 | Pubmed ID: 19074893
The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer.
Molecular cancer therapeutics Aug, 2009 | Pubmed ID: 19671764
Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy.
Human gene therapy Jan, 2010 | Pubmed ID: 19715403
Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.
Cancer cell Sep, 2009 | Pubmed ID: 19732719
Expression of IFN-beta enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesothelioma.
Cancer research Oct, 2009 | Pubmed ID: 19773437
CCL2 blockade augments cancer immunotherapy.
Cancer research Jan, 2010 | Pubmed ID: 20028856
Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).
The Journal of biological chemistry Apr, 2010 | Pubmed ID: 20118240
Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.
American journal of respiratory cell and molecular biology Feb, 2011 | Pubmed ID: 20395632
Association between CD14 gene polymorphisms and disease phenotype in sarcoidosis.
Respiratory medicine Sep, 2010 | Pubmed ID: 20430603
Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms.
Molecular therapy : the journal of the American Society of Gene Therapy Nov, 2010 | Pubmed ID: 20683443
Pharmacologic activation of the innate immune system to prevent respiratory viral infections.
American journal of respiratory cell and molecular biology Sep, 2011 | Pubmed ID: 21148741
Sildenafil to facilitate weaning from inhaled nitric oxide and mechanical ventilation in a patient with severe secondary pulmonary hypertension and a patent foramen ovale.
Respiratory care Oct, 2011 | Pubmed ID: 21513610
Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation.
Biochemical pharmacology Nov, 2011 | Pubmed ID: 21819972
Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicity.
Molecular therapy : the journal of the American Society of Gene Therapy Apr, 2012 | Pubmed ID: 22008913
Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils.
PloS one , 2012 | Pubmed ID: 22348096
Tumor-associated neutrophils: friend or foe?
Carcinogenesis May, 2012 | Pubmed ID: 22425643
Characterization of surgical models of postoperative tumor recurrence for preclinical adjuvant therapy assessment.
American journal of translational research , 2012 | Pubmed ID: 22611473
A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation.
Cancer biology & therapy Jul, 2012 | Pubmed ID: 22617772
Randomized controlled crossover trial of a new oscillatory device as add-on therapy for COPD.
COPD Dec, 2012 | Pubmed ID: 23215916
Modifying tumor-associated macrophages: An important adjunct to immunotherapy.
Oncoimmunology Dec, 2013 | Pubmed ID: 24498549
Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17--a new mechanism of impaired antitumor immunity.
International journal of cancer. Journal international du cancer Sep, 2014 | Pubmed ID: 24501019
The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment.
Cancer microenvironment : official journal of the International Cancer Microenvironment Society Jun, 2014 | Pubmed ID: 24895166
Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer.
Cell reports Feb, 2015 | Pubmed ID: 25620698
Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma.
Immunology letters May, 2015 | Pubmed ID: 25999306
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados